Detalles de la búsqueda
1.
One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration.
Eye (Lond)
; 31(6): 878-883, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28186507
2.
Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group.
Eye (Lond)
; 31(11): 1582-1588, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28622328
3.
A systematic review to assess the 'treat-and-extend' dosing regimen for neovascular age-related macular degeneration using ranibizumab.
Eye (Lond)
; 31(9): 1337-1344, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28475181
4.
Reply to: 'Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'.
Eye (Lond)
; 32(2): 479-481, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29052610
Resultados
1 -
4
de 4
1
Próxima >
>>